ZA945214B - Tris carbamic acid esters: inhibitors of cholesterol absorption - Google Patents
Tris carbamic acid esters: inhibitors of cholesterol absorptionInfo
- Publication number
- ZA945214B ZA945214B ZA945214A ZA945214A ZA945214B ZA 945214 B ZA945214 B ZA 945214B ZA 945214 A ZA945214 A ZA 945214A ZA 945214 A ZA945214 A ZA 945214A ZA 945214 B ZA945214 B ZA 945214B
- Authority
- ZA
- South Africa
- Prior art keywords
- tris
- inhibitors
- acid esters
- carbamic acid
- cholesterol absorption
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/095,140 US5952354A (en) | 1993-07-21 | 1993-07-21 | Tris carbamic acid esters: inhibitors of cholesterol absorption |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA945214B true ZA945214B (en) | 1996-01-15 |
Family
ID=22250071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA945214A ZA945214B (en) | 1993-07-21 | 1994-07-15 | Tris carbamic acid esters: inhibitors of cholesterol absorption |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5952354A (xx) |
| EP (1) | EP0635501A1 (xx) |
| JP (1) | JPH0789934A (xx) |
| KR (1) | KR950003269A (xx) |
| AU (1) | AU692157B2 (xx) |
| BR (1) | BR9402852A (xx) |
| CA (1) | CA2128116A1 (xx) |
| FI (1) | FI943441A (xx) |
| HU (1) | HU216790B (xx) |
| IL (1) | IL110302A (xx) |
| MX (1) | MX9405430A (xx) |
| NZ (1) | NZ264032A (xx) |
| RU (1) | RU2130928C1 (xx) |
| SG (1) | SG47596A1 (xx) |
| TW (1) | TW369527B (xx) |
| ZA (1) | ZA945214B (xx) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5527804A (en) * | 1994-06-13 | 1996-06-18 | American Home Products Corporation | 4-carbamoyloxy-piperidine-1-carboxylic acid esters: inhibitors or cholesterol absorption |
| KR100388345B1 (ko) | 1995-10-05 | 2004-03-30 | 교토 야쿠힝 고교 가부시키가이샤 | 신규헤테로시클릭유도체및이것의의약용도 |
| US5952506A (en) * | 1997-04-24 | 1999-09-14 | American Home Products Corporation | Process for the synthesis of 4- 6- (hexylcarbamoyloxy) hexylcarbamoyloxy!-piperidine-1-carboxylic acid 4-phenoxyphenyl ester |
| WO1998047870A1 (en) * | 1997-04-24 | 1998-10-29 | American Home Products Corporation | Process for the synthesis of 4-[6-(hexylcarbamoyloxy) hexylcarbamoyloxy]-piperidine-1- carboxylic acid 4-phenoxyphenyl ester |
| EP2234493A4 (en) * | 2007-12-21 | 2011-05-25 | Univ Cincinnati | THERAPEUTIC USE OF CARBOXYLESTERLIPASE INHIBITORS |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2800105A1 (de) * | 1977-01-11 | 1978-07-13 | Ciba Geigy Ag | Verwendung von diphenylaethern als algizide |
| JPS5671058A (en) * | 1979-11-12 | 1981-06-13 | Mitsui Toatsu Chem Inc | Phenoxyphenylcarbamic ester derivative |
| DE3702876A1 (de) * | 1987-01-31 | 1988-08-11 | Merck Patent Gmbh | Optisch aktive verbindungen |
| FR2612186B1 (fr) * | 1987-03-09 | 1989-07-21 | Poudres & Explosifs Ste Nale | Carbonyl 2,2' bis (alkyl-4 oxadiazolidines-1,2,4-diones-3,5), leur procede de preparation et leur utilisation comme intermediaires de synthese dans la preparation de carbamates |
| US5142094A (en) * | 1989-11-06 | 1992-08-25 | Warner-Lambert Company | Aryl substituted carbamate derivatives which are acat inhibitors |
| IL95994A0 (en) * | 1989-11-15 | 1991-07-18 | American Home Prod | Carbamate esters and pharmaceutical compositions containing them |
| US5112859A (en) * | 1990-09-14 | 1992-05-12 | American Home Products Corporation | Biphenyl amide cholesterol ester hydrolase inhibitors |
| US5169844A (en) * | 1991-12-20 | 1992-12-08 | American Home Products Corporation | 4-substituted piperidinecarboxylic acid esters: inhibition of cholesterol absorption |
-
1993
- 1993-07-21 US US08/095,140 patent/US5952354A/en not_active Expired - Fee Related
-
1994
- 1994-01-10 TW TW083100154A patent/TW369527B/zh active
- 1994-07-13 IL IL110302A patent/IL110302A/en not_active IP Right Cessation
- 1994-07-15 MX MX9405430A patent/MX9405430A/es unknown
- 1994-07-15 ZA ZA945214A patent/ZA945214B/xx unknown
- 1994-07-15 RU RU94026296A patent/RU2130928C1/ru active
- 1994-07-15 CA CA002128116A patent/CA2128116A1/en not_active Abandoned
- 1994-07-15 HU HU9402108A patent/HU216790B/hu not_active IP Right Cessation
- 1994-07-18 NZ NZ264032A patent/NZ264032A/en unknown
- 1994-07-18 BR BR9402852A patent/BR9402852A/pt not_active Application Discontinuation
- 1994-07-18 AU AU67520/94A patent/AU692157B2/en not_active Ceased
- 1994-07-18 JP JP6165075A patent/JPH0789934A/ja active Pending
- 1994-07-18 KR KR1019940017234A patent/KR950003269A/ko not_active Application Discontinuation
- 1994-07-19 SG SG1996003025A patent/SG47596A1/en unknown
- 1994-07-19 EP EP94305305A patent/EP0635501A1/en not_active Ceased
- 1994-07-20 FI FI943441A patent/FI943441A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2128116A1 (en) | 1995-01-22 |
| AU6752094A (en) | 1995-02-02 |
| KR950003269A (ko) | 1995-02-16 |
| MX9405430A (es) | 1995-01-31 |
| RU94026296A (ru) | 1997-05-27 |
| FI943441A0 (fi) | 1994-07-20 |
| NZ264032A (en) | 1995-12-21 |
| FI943441A (fi) | 1995-01-22 |
| JPH0789934A (ja) | 1995-04-04 |
| BR9402852A (pt) | 1995-04-04 |
| SG47596A1 (en) | 1998-04-17 |
| HU9402108D0 (en) | 1994-09-28 |
| US5952354A (en) | 1999-09-14 |
| HU216790B (hu) | 1999-08-30 |
| TW369527B (en) | 1999-09-11 |
| IL110302A0 (en) | 1994-10-21 |
| HUT70942A (en) | 1995-11-28 |
| AU692157B2 (en) | 1998-06-04 |
| EP0635501A1 (en) | 1995-01-25 |
| IL110302A (en) | 1998-06-15 |
| RU2130928C1 (ru) | 1999-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0606899A3 (en) | Processes for the preparation of optically active 4-halo-3-hydroxy butyric acid esters. | |
| ZA945189B (en) | Sulfonation of fatty acid esters | |
| FI940874A0 (fi) | Menetelmä maitohapon ja maitohappoestereiden valmistamiseksi | |
| SG81884A1 (en) | Process for the production of methacrylic acid esters | |
| ZA948784B (en) | Isethionate esters of alkyl alkoxylic acid | |
| AU5323694A (en) | 17beta -carboxanilides of 4-aza-5alpha-androstan-3-ones as 5alpha-reductase inhibitors | |
| HU9302150D0 (en) | Oplant protecting preparatives containing substituted acrylic acid esters and method for producing said active substance | |
| HU9402108D0 (en) | Tris carbamic acid esters: inhibitors of cholesterol absorption | |
| AU3425193A (en) | 4-substituted piperidinecarboxylic acid esters: inhibition of cholesterol absorption | |
| ZA946065B (en) | Process for the removal of lead and cadmium form phosphoric acid | |
| GB2238542B (en) | Cholesterol ester hydrolase inhibitors | |
| AU7534894A (en) | 3-methoxy-2-phenylacrylic acid methyl esters | |
| ZA942082B (en) | Boronic acid and ester inhibitors of thrombin | |
| HU9603414D0 (en) | 4-carbamoyloxy-piperidine-1-carboxylic acid esters: inhibitors of cholesterol absorption | |
| AU3113095A (en) | Production of carbamic acid vinyl esters | |
| AU6205394A (en) | Use of omega-guanidinocarboxylic acid esters | |
| EP0560158A3 (en) | Process for the preparation of beta-aminoacrylic acid esters | |
| AU664084B2 (en) | Novel thiosemicarbazonic acid esters | |
| AU1067995A (en) | Use of carbamide acid esters as crystallisation inhibitors | |
| AU7994294A (en) | Use of phosphonic acid esters as crystallization inhibitors | |
| AU1577195A (en) | Use of dicarboxylic acid bis-dimethylamides as crystallisation inhibitors | |
| IL111183A0 (en) | Process for the preparation of 5-fluoroanthranilic acid | |
| ZA949053B (en) | Use of phosphoric esters as crystallisation inhibitors | |
| ZA949325B (en) | Novel substituted thiosemicarbazonic acid esters | |
| HU9502056D0 (en) | Novel substituted thiosemicarbanozic acid esters |